Cargando…

Comprehensive analysis of circulating microRNAs as predictive biomarkers for sorafenib therapy outcome in hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related death worldwide. Clinical management has improved the prognosis of early HCC, but that of advanced HCC remains poor. Sorafenib, an oral multikinase inhibitor, provided a treatment option for advanced-stage HCC, and prolonged...

Descripción completa

Detalles Bibliográficos
Autores principales: Kohno, Tomoki, Morishita, Asahiro, Iwama, Hisakazu, Fujita, Koji, Tani, Joji, Takuma, Kei, Nakahara, Mai, Oura, Kyoko, Tadokoro, Tomoko, Nomura, Takako, Yoneyama, Hirohito, Kato, Kiyohito, Okano, Keiichi, Suzuki, Yasuyuki, Nishiyama, Akira, Himoto, Takashi, Masaki, Tsutomu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7377167/
https://www.ncbi.nlm.nih.gov/pubmed/32724415
http://dx.doi.org/10.3892/ol.2020.11696